Study to ease cancer-related distress needs survivors

Article

The National Cancer Institute estimates over a third of survivors experience significant levels of distress linked to their cancer experiences. And while psychosocial interventions may help alleviate that distress, many survivors are unable to access or find the appropriate tools for assistance. This is why the NCI is sponsoring a nationwide clinical trial to identify how to help distressed cancer survivors. In conjunction with Loma Linda University, the NCI has developed an accessible Internet-based intervention program that hopes to improve quality of life and reduce mood disturbances for survivors. Jason Owen, PhD, an associate professor of psychology at Loma Linda University and lead investigator on the trial, described the program to me. It's a 12-week online program that includes a group discussion board, weekly chat conversations that are professionally facilitated and personal pages. Each week a different coping exercise is focused on, and participants are encouraged to share their experiences with each other. Participants can use the site as much or as little as they wish, although they are encouraged to attend the weekly chat conversations (currently on Wednesdays at 7-8:30 p.m. EST) to get to know other survivors and learn from each other. All information is password-protected and anonymous. The program is free to any cancer survivors at any stage of treatment or follow-up as long as they are over age 18 and are experiencing distress. You must have access to the Internet and are willing to complete a few questionnaires as part of the trial. For more information, check out www.health-space.net or call 1-800-395-1525. Only a handful of studies have examined the benefits of Internet-based interventions for treating distress in cancer survivors. Your participation in this study can help develop programs that are accessible to anyone with a computer. But most importantly, sharing your experiences with other survivors can be a step toward healing and toward helping others while helping yourself.

Related Videos
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Yuliya P.L Linhares, MD, an expert on CLL
Yuliya P.L Linhares, MD, and Josie Montegaard, MSN, AGPCNP-BC, experts on CLL
Image of a man with a beard.
Image of a man with gray facial hair and a navy blue suit with a light orange tie.
Image of a woman with black hair.
Related Content